Hypothesizing that designer drugs containing cathinones (“bath salts”) have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption

Karila, 2012, Synthetic drugs: the new low-cost landscape of drugs, Rev Prat, 62, 664 Penders, 2012, Excited delirium following use of synthetic cathinones (bath salts), Gen Hosp Psychiatry, 34, 647, 10.1016/j.genhosppsych.2012.06.005 Coppola, 2012, 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online, Toxicol Lett, 208, 12, 10.1016/j.toxlet.2011.10.002 Prosser, 2012, The toxicology of bath salts: a review of synthetic cathinones, J Med Toxicol, 8, 33, 10.1007/s13181-011-0193-z Robinson, 2012, Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine, Behav Brain Res, 234, 76, 10.1016/j.bbr.2012.06.012 Simmler, 2012, Pharmacological characterization of designer cathinones in vitro, Br J Pharmacol, 168, 458, 10.1111/j.1476-5381.2012.02145.x Baumann, 2012, The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue, Neuropsychopharmacology, 37, 1192, 10.1038/npp.2011.304 Hadlock, 2011, 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse, J Pharmacol Exp Ther, 339, 530, 10.1124/jpet.111.184119 Kehr, 2011, Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats, Br J Pharmacol, 164, 1949, 10.1111/j.1476-5381.2011.01499.x Ramoz, 2012, Mephedrone (“bath salt”) pharmacology: insights from invertebrates, Neuroscience, 208, 79, 10.1016/j.neuroscience.2012.01.019 Lisek, 2012, Mephedrone (‘bath salt’) elicits conditioned place preference and dopamine-sensitive motor activation, Drug Alcohol Depend, 126, 257, 10.1016/j.drugalcdep.2012.04.021 Robinson, 2012, Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine, Behav Brain Res, 234, 76, 10.1016/j.bbr.2012.06.012 Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Grabenauer M, Thomas BF, et al. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol. 2012. http://dx.doi.org/10.1111/j.1369-1600.2012.00474.x. [Epub ahead of print]. Watterson, 2012, Evaluation of the abuse potential of MDVP and Methylone, two common synthetic cathinones found in bath salts” (abstract), J Addict Res Ther, 3, 101 Angoa-Pérez, 2012, Mephedrone, an abused psychoactive component of ‘bath salts’ and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum, J Neurochem, 120, 1097 2011, Centers for Disease Control and Prevention [CDC] Emergency department visits after use of a drug sold as “bath salts”-Michigan, November 13, 2010-March 31, 2011, MMWR Morb Mortal Wkly Rep, 60, 624 Thornton, 2012, Psychosis from a Bath Salt product containing flephedrone and MDPV with serum, urine, and product quantification, J Med Toxicol, 8, 310, 10.1007/s13181-012-0232-4 Wieland, 2012, Bath salts: they are not what you think, J Psychosoc Nurs Ment Health Serv, 50, 17, 10.3928/02793695-20120120-01 Meyer, 2012, New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC–MS and LC-high-resolution MS and their detectability in urine, J Mass Spectrom, 47, 253, 10.1002/jms.2960 Spiller, 2011, Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States, Clin Toxicol (Phila), 49, 499, 10.3109/15563650.2011.590812 Kobeissy, 2006, Differential proteomic analysis of traumatic brain injury biomarker study using CAX-PAGE/RPLC-MSMS method, Mol Cell Proteomics, 5, 1887, 10.1074/mcp.M600157-MCP200 Warren, 2006, Ecstasy toxicity: a comparison to methamphetamine and traumatic brain injury, J Addict Dis, 25, 115, 10.1300/J069v25n04_11 Warren, 2005, Concurrent calpain and caspase-3 mediated proteolysis of αII-spectrin and tau in rat brain after methamphetamine exposure: a similar profile to traumatic brain injury, Life Sci, 78, 301, 10.1016/j.lfs.2005.04.058 Kobeissy, 2008, Psychoproteomic analysis of rat cortex following acute methamphetamine exposure, J Proteome Res, 7, 1971, 10.1021/pr800029h Gold, 2009, Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates, Biol Psychiat, 66, 118, 10.1016/j.biopsych.2009.02.021 Kobeissy, 2009, Methods in drug abuse neuroproteomics: methamphetamine psychoproteome, Methods Mol Biol, 566, 217, 10.1007/978-1-59745-562-6_15 Sekine, 2008, Methamphetamine causes microglial activation in the brains of human abusers, J Neurosci, 28, 5756, 10.1523/JNEUROSCI.1179-08.2008 “Findings of the Attorney General In Support of Emergency Rule 2ER11-1”. State of Florida, Office of the Attorney General Emergency Rule ER11-1. Jan. 26 2011. Ross, 2012, Psychoactive “bath salts” intoxication with methylenedioxypyrovalerone. 2012, Am J Med, 125, 854, 10.1016/j.amjmed.2012.02.019 Krimer, 1998, Dopaminergic regulation of cerebral cortical microcirculation, Nature Neurosci, 1, 286, 10.1038/1099 Murray, 2012, Death following recreational use of designer drug “bath salts” containing 3,4-Methylenedioxypyrovalerone (MDPV), J Med Toxicol, 8, 69, 10.1007/s13181-011-0196-9